Form 4 for ABT Abbott Laboratories
Accepted 2025-01-31 00:00:00 ET · period of report 2025-01-30 · accession 0001415889-25-002584 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-31 | 2025-01-30 | ABT | Salvadori Daniel Gesua Sive | EVP | S - Sale+OE | $128.50 | -23.8K | 125.7K | -16% | -$3.05M |
| D | 2025-01-31 | 2025-01-30 | ABT | Salvadori Daniel Gesua Sive | EVP | M - OptEx | $38.40 | +23.8K | 149.5K | +19% | +$912.8K |
| D | 2025-01-31 | 2025-01-30 | ABT | Salvadori Daniel Gesua Sive | EVP | M - OptEx | $0.00 | -23.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2025-01-30 | S | D | 23,771 | $128.50 | 125,697 | D | — | — | |
| 2 | Common | Common shares without par value | 2025-01-30 | M | A | 23,771 | $38.40 | 149,468 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2025-01-30 | M | D | 23,771 | $0.00 | 0 | D | $38.40 · 2019-02-19 to 2026-02-18 | 23,771 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |